118 related articles for article (PubMed ID: 30027096)
1. Development of Novel Single-Chain Antibodies against the Hydrophobic HPV-16 E5 Protein.
Monjarás-Ávila C; Bernal-Silva S; Bach H
Biomed Res Int; 2018; 2018():5809028. PubMed ID: 30027096
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 16 E5 protein as a therapeutic target.
Kim SW; Yang JS
Yonsei Med J; 2006 Feb; 47(1):1-14. PubMed ID: 16502480
[TBL] [Abstract][Full Text] [Related]
3. The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes.
Sudarshan SR; Schlegel R; Liu X
Biochem Biophys Res Commun; 2010 Sep; 399(4):617-22. PubMed ID: 20688044
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A*0201-restricted T-cell peptides in cervical cancer patients.
Liu DW; Yang YC; Lin HF; Lin MF; Cheng YW; Chu CC; Tsao YP; Chen SL
J Virol; 2007 Mar; 81(6):2869-79. PubMed ID: 17202211
[TBL] [Abstract][Full Text] [Related]
5. Identification of immunotherapeutic epitope of E5 protein of human papillomavirus-16: An in silico approach.
Kumar A; Yadav IS; Hussain S; Das BC; Bharadwaj M
Biologicals; 2015 Sep; 43(5):344-8. PubMed ID: 26212000
[TBL] [Abstract][Full Text] [Related]
6. In vivo HPV 16 E5 mRNA: expression pattern in patients with squamous intra-epithelial lesions of the cervix.
Lorenzon L; Mazzetta F; Venuti A; Frega A; Torrisi MR; French D
J Clin Virol; 2011 Oct; 52(2):79-83. PubMed ID: 21767984
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effects of genetic vaccines against HPV major oncogenes.
Cordeiro MN; Paolini F; Massa S; Curzio G; Illiano E; Duarte Silva AJ; Franconi R; Bissa M; Morghen Cde G; de Freitas AC; Venuti A
Hum Vaccin Immunother; 2015; 11(1):45-52. PubMed ID: 25483514
[TBL] [Abstract][Full Text] [Related]
9. The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix.
Chang JL; Tsao YP; Liu DW; Huang SJ; Lee WH; Chen SL
J Biomed Sci; 2001; 8(2):206-13. PubMed ID: 11287752
[TBL] [Abstract][Full Text] [Related]
10. Two conserved amino acids differentiate the biology of high-risk and low-risk HPV E5 proteins.
Sudarshan SR; Schlegel R; Liu X
J Med Virol; 2022 Sep; 94(9):4565-4575. PubMed ID: 35509176
[TBL] [Abstract][Full Text] [Related]
11. hrHPV E5 oncoprotein: immune evasion and related immunotherapies.
de Freitas AC; de Oliveira THA; Barros MR; Venuti A
J Exp Clin Cancer Res; 2017 May; 36(1):71. PubMed ID: 28545552
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 16 E5 protein induces expression of beta interferon through interferon regulatory factor 1 in human keratinocytes.
Muto V; Stellacci E; Lamberti AG; Perrotti E; Carrabba A; Matera G; Sgarbanti M; Battistini A; Liberto MC; Focà A
J Virol; 2011 May; 85(10):5070-80. PubMed ID: 21389130
[TBL] [Abstract][Full Text] [Related]
13. E5HPV16 mRNA EXPRESSION PATTERN ANALYSIS IN PATIENTS WITH CERVICAL LESIONS IN VIRAL STATUS CONTEXT.
Iancu IV; Pleşa A; Botezatu A; Huică I; Stănescu AD; Socolov D; Anton G
Roum Arch Microbiol Immunol; 2015; 74(1-2):33-9. PubMed ID: 26727852
[TBL] [Abstract][Full Text] [Related]
14. Detection of E5 oncoprotein in human papillomavirus type 16-positive cervical scrapes using antibodies raised to synthetic peptides.
Kell B; Jewers RJ; Cason J; Pakarian F; Kaye JN; Best JM
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2451-6. PubMed ID: 8077947
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment.
Kim MK; Kim HS; Kim SH; Oh JM; Han JY; Lim JM; Juhnn YS; Song YS
Biochem Pharmacol; 2010 Dec; 80(12):1930-5. PubMed ID: 20643111
[TBL] [Abstract][Full Text] [Related]
16. Variable expression of the forgotten oncogene E5 in HPV-positive oropharyngeal cancer.
Um SH; Mundi N; Yoo J; Palma DA; Fung K; MacNeil D; Wehrli B; Mymryk JS; Barrett JW; Nichols AC
J Clin Virol; 2014 Sep; 61(1):94-100. PubMed ID: 25027574
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of MHC class I is a property common to papillomavirus E5 proteins.
Ashrafi GH; Brown DR; Fife KH; Campo MS
Virus Res; 2006 Sep; 120(1-2):208-11. PubMed ID: 16780984
[TBL] [Abstract][Full Text] [Related]
18. Antibody response for L1, E6, E7 HPV 16, and HPV 18 antigens in Tunisian women with cervical cancer.
Achour M; Zeghal D; Kochbati L; Kahla S; Zouari F; Maâlej M; Oueslati R
J Immunoassay Immunochem; 2009; 30(1):82-96. PubMed ID: 19117204
[TBL] [Abstract][Full Text] [Related]
19. HPV: from infection to cancer.
Stanley MA; Pett MR; Coleman N
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1456-60. PubMed ID: 18031245
[TBL] [Abstract][Full Text] [Related]
20. Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.
Berger KL; Barriga F; Lace MJ; Turek LP; Zamba GJ; Domann FE; Lee JH; Klingelhutz AJ
Virology; 2006 Dec 5-20; 356(1-2):68-78. PubMed ID: 16945398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
